newsfilter
← Latest News
Business Wire·

Cresco Labs CEO: Rescheduling Ushers in a New Era of Care for Medical Cannabis Patients

Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) ("Cresco Labs" or the "Company"), today issued a statement on behalf of Cresco Labs CEO Charlie Bachtell in response to the Department of Justice's final rule